189 results
Page 6 of 10
8-K
EX-10.3
r42xm tpx0xzgbass
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
8-K
nqo5rg 5sd3v6tcbpeu
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
8-K
EX-10.2
m5wlea4pztlz
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
425
ysen5xl
24 Jun 20
Business combination disclosure
4:03pm
425
a1gqyig21srlwsl7g
22 Jun 20
Business combination disclosure
5:30pm
8-K
EX-99.2
gpj8h
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.3
wk93eyrto
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.1
g57wkzxaung9rq7my5q
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.4
870q9g6o5e ou
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.1
3aj0vn1rae
5 May 20
Invitae Reports More Than $64 Million in Revenue Driven by More Than 154,000 Samples Accessioned in the First Quarter of 2020
4:11pm
S-3ASR
pju9k4 qkbuyyd6axjbg
20 Apr 20
Automatic shelf registration
4:59pm
S-3ASR
c7awdoirawo647 xwb
20 Apr 20
Automatic shelf registration
4:55pm
8-K
EX-99.1
niykbk5 8kiy6m
6 Apr 20
Invitae Announces Pricing of Public Offering of Common Stock
5:00pm
8-K
b783l
1 Apr 20
Regulation FD Disclosure
4:39pm
8-K
v1t7k 6i01
1 Apr 20
Invitae Announces Proposed Public Offering of Common Stock
4:34pm
8-K
EX-99.1
kxf2 7dagc4rra
1 Apr 20
Invitae Announces Proposed Public Offering of Common Stock
4:34pm
S-3ASR
lahxo8f 5a0k
18 Mar 20
Automatic shelf registration
10:00pm